New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-02-01
著者
-
MIYAGAWA JUN-ICHIRO
Division of Diabetes & Metabolism, Internal Medicine, Hyogo College of Medicine
-
Namba Mitsuyoshi
Division Of Diabetes And Metabolism Department Of Internal Medicine Hyogo College Of Medicine
-
Katsuno Tomoyuki
Division Of Diabetes And Metabolism Department Of Internal Medicine Hyogo College Of Medicine
-
Miuchi Masayuki
Division Of Diabetes And Metabolism Department Of Internal Medicine Hyogo College Of Medicine
-
Kusunoki Yoshiki
Division Of Diabetes And Metabolism Department Of Internal Medicine Hyogo College Of Medicine
-
MATSUO Toshihiro
Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine
関連論文
- The-1535 Promoter Variant of The Visfatin Gene Is Associated with Serum Triglyceride and HDL-cholesterol Levels in Japanese Subjects
- Giant Intrasellar Arachnoid Cyst Manifesting as Adrenal Insufficiency Due to Hypothalamic Dysfunction : Case Report
- Exenatide Exhibits Dose-Dependent Effects on Glycemic Control over 12 Weeks in Japanese Patients with Suboptimally Controlled Type 2 Diabetes
- SDTラットの膵島障害進展におけるマクロファージの役割
- Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
- The PREDICTIVE^ Study : a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes-data from the Japan cohort
- International clinical harmonization of glycated hemoglobin in Japan : From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
- New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
- Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus